Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| AVANIR PHARMACEUTICALS | 65,690 | reported | 09 Sept 2011 | tx 47+1,361,286−374,652 |
| Axsome Therapeutics, Inc. | 6,022 | reported | 23 Dec 2015 | tx 3+11,044 |
| Longboard Pharmaceuticals, Inc. | 0 | reported | 02 Dec 2024 | tx 28+568,434−568,434 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 02 Dec 2024 | TENDER | Longboard Pharmaceuticals, Inc. | 30,554 | 60.00 USD | |
| 02 Dec 2024 | OTHER | Longboard Pharmaceuticals, Inc. | 107,560 | — | deriv |
| 02 Dec 2024 | OTHER | Longboard Pharmaceuticals, Inc. | 96,300 | — | deriv |
| 02 Dec 2024 | OTHER | Longboard Pharmaceuticals, Inc. | 175,946 | — | deriv |
| 02 Dec 2024 | OTHER | Longboard Pharmaceuticals, Inc. | 17,920 | — | deriv |
| 02 Dec 2024 | OTHER | Longboard Pharmaceuticals, Inc. | 9,500 | — | deriv |
| 19 Nov 2024 | EXERCISE | Longboard Pharmaceuticals, Inc. | 30,554 | 6.00 USD | |
| 19 Nov 2024 | EXERCISE | Longboard Pharmaceuticals, Inc. | 30,554 | 0.00 USD | deriv |
| 25 Oct 2024 | GRANT_AWARD | Longboard Pharmaceuticals, Inc. | 9,500 | 0.00 USD | deriv |
| 15 Oct 2024 | EXERCISE | Longboard Pharmaceuticals, Inc. | 16,667 | 4.35 USD | |
| 15 Oct 2024 | SALE | Longboard Pharmaceuticals, Inc. | 16,667 | 59.04 USD | |
| 15 Oct 2024 | EXERCISE | Longboard Pharmaceuticals, Inc. | 16,667 | 0.00 USD | deriv |
| 16 Sept 2024 | SALE | Longboard Pharmaceuticals, Inc. | 1,200 | 33.12 USD | |
| 16 Sept 2024 | SALE | Longboard Pharmaceuticals, Inc. | 1,900 | 34.04 USD | |
| 16 Sept 2024 | EXERCISE | Longboard Pharmaceuticals, Inc. | 16,666 | 4.35 USD | |
| 16 Sept 2024 | SALE | Longboard Pharmaceuticals, Inc. | 9,366 | 30.89 USD | |
| 16 Sept 2024 | SALE | Longboard Pharmaceuticals, Inc. | 4,200 | 31.81 USD | |
| 16 Sept 2024 | EXERCISE | Longboard Pharmaceuticals, Inc. | 16,666 | 0.00 USD | deriv |
| 12 Aug 2024 | SALE | Longboard Pharmaceuticals, Inc. | 6,191 | 35.03 USD | |
| 25 Jun 2024 | SALE | Longboard Pharmaceuticals, Inc. | 100 | 20.87 USD | |
| 12 Aug 2024 | EXERCISE | Longboard Pharmaceuticals, Inc. | 16,667 | 4.35 USD | |
| 12 Aug 2024 | SALE | Longboard Pharmaceuticals, Inc. | 10,476 | 34.55 USD | |
| 23 Jan 2024 | PURCHASE | Longboard Pharmaceuticals, Inc. | 100 | 24.82 USD | first after silence |
| 12 Aug 2024 | EXERCISE | Longboard Pharmaceuticals, Inc. | 16,667 | 0.00 USD | deriv |
| 08 Feb 2024 | GRANT_AWARD | Longboard Pharmaceuticals, Inc. | 17,920 | 0.00 USD |
3 purchases reported after at least 12 months of silence — most recent on 23 Jan 2024.